In industry parlance, it is reverse logistics. What it means is managing the return of parts and equipment for repair or substitution. GE Medical Systems has recruited BAX Global to handle this dark side of sales. Under the contract, the supply-chain
In industry parlance, it is reverse logistics. What it means is managing the return of parts and equipment for repair or substitution. GE Medical Systems has recruited BAX Global to handle this dark side of sales. Under the contract, the supply-chain management company will usher equipment rejected by clinics and hospitals to GE’s regional repair centers. GE’s 2000 field engineers will now be calling on BAX to handle their parts or equipment pickups inside hospitals. BAX will then follow through with the shipment of items that need repair to regional locations throughout the country. The company won the contract by promising reduced transportation costs and improved cycle time. BAX has been targeting the technology, aerospace, and healthcare markets, as they fit within the company’s core logistics competencies and experience. These markets account for the largest share of the company’s growth on a global basis.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.